suggested an increased risk of complications among older patients undergoing this procedure. 12 Physiologic changes that occur as women age are known to affect wound healing 13 and may play a role in surgical outcomes for older patients presenting for reduction mammaplasty. 12 However, the increased risk of complications among older patients has not been demonstrated in other studies or on a population level.
The purpose of our study is to use the large validated 14 American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database to better understand how age affects the risk of early postoperative complications in reduction mammaplasty. These results can then be utilized to better risk-stratify and counsel older patients who present for this potentially complex but lifechanging procedure.
MethodS

Patient Identification
We reviewed the 2005-2010 ACS NSQIP database participant use data files, 15 and the 2012 Current Procedural Terminology code of 19318 was used to define reduction mammaplasty. More than 250 academic and community hospitals in the United States were included in the data, which were accessed on December 1, 2012. A total of 3537 cases of reduction mammaplasty from the ACS NSQIP database were ultimately included in this study.
Our institution approved an Institutional Review Board exemption to complete this study. More than 200 ACS NSQIP-defined variables were included, such as 30-day postoperative morbidity, laboratory values, preoperative medical comorbidities, and patient demographics. Patients without full 30-day follow-up were excluded from the final yearly data set. Follow-up was obtained by trained research staff via mail or telephone conversations with patients or providers.
We examined the following outcome variables from the data set: superficial surgical site infection (SSSI), deep surgical site infection (DSSI), organ space infection, wound dehiscence, pulmonary embolism, deep venous thrombosis, pneumonia, renal insufficiency, renal failure, urinary tract infection, sepsis, septic shock, return to the operating room, and myocardial infarction. In addition to ACS NSQIP-defined variables, the following composite variables were created to increase the power of our analysis: major surgical complications (DSSI, unplanned return to the operating room), major wound complication (SSSI, wound dehiscence), any surgical complication (DSSI, SSSI, unplanned return to the operating room, wound dehiscence) and major medical complication (pneumonia, pulmonary embolism, renal insufficiency, urinary tract infection, deep venous thrombosis, sepsis). Based on the World Health Organization's definition of elderly (>60 years), 2 groups of patients were initially compared: <60 and ≥ 60 years. We then further stratified the cohorts into 3 groups (<40, 50-60, and >60 years) to allow direct comparison to a previously conducted study.
7,12
Statistical Analysis
Univariate analyses were performed with Wilcoxon ranksum, Pearson chi-squared, and Fisher exact tests to understand the effects of age on surgical outcomes. All calculations were done with Stata/IC 10.0 (StataCorp, College Station, Texas).
ReSultS
Patient Demographics and Comorbidities
Of the 3537 patients in this study, 3050 (86.2%) were younger than 60 years (39.7 ± 11.8 years), and 487 (13.8%) were older than 60 years (65.1 ± 4.7 years). The ages of the cohort ranged from 16 to 86 years (43.2 ± 14.1 years). A history of hypertension was the largest comorbid factor for both younger (n = 595) and older (n = 255) patients (P < .001; Table 1 ).
The number of reduction mammaplasties in the ACS NSQIP database ranged from 15 in the first year of collection to 1664 in the most recent year (P < .001). For patients younger than 60 years, reduction mammaplasty was performed as an inpatient procedure in 571 cases (18.7%). For those older than 60 years, 120 cases (24.6%) were performed as inpatient procedures (P = .002). In all, 26.3% of patients older than 60 years and 10.6% of younger patients were graded as American Society of Anesthesiologists Class 3 (P < .001). Operative time was higher in the younger patient cohort (181.9 ± 70.0 minutes) than in the older cohort (173.3 ± 81.8 minutes; P < .001). The length of hospital stay was an average of 0.8 ± 4.9 days for the younger cohort and 0.7 ± 0.9 days for older patients (P = .006; Table 2 ).
A total of 182 early postoperative surgical complications were documented for this patient population. Wound complications (n = 127) were the most common. When analyzing age as a risk factor for complications after breast reduction surgery, we noted that age was not associated with any of the 30-day outcomes in the ACS NSQIP database or with any of our composite variables ( Table 3) .
The study population was later stratified into 3 age groups. We found that 1435 patients were younger than 40 years old (29.0 ± 6.5 years), 915 were 40-50 years old (45.1 ± 3.2 years), and 1187 were older than 50 years (58.9 ± 6.3 years). Patients older than 50 were found to have the largest percentage of perioperative comorbidities, including hypertension (43.6%; n = 518), steroid use (1.7%; n = 20), history of chronic obstructive pulmonary disease (1.8%; n = 21), and history of percutaneous coronary intervention (1.7%; n = 20). Of the patients older than 50, 23.5% (n = 279) underwent reduction mammaplasty as an inpatient procedure. Even with additional cohort stratification, we again found no association with any ACS NSQIP or composite outcome variables (Table 4) .
diScuSSion
Because of the aging population, there has been increased interest in health care outcomes and costs for older patients. In the United States, greater emphasis is being placed on avoiding preventable complications, which result in increased costs and resource utilization for the health care system and physical burdens on patients. Furthermore, in a generally fee-for-service system, such complications may not be reimbursed, passing the costs directly to the health system. As such, better risk stratification, preoperative optimization, and patient selection are increasingly important.
For breast reduction surgery, conflicting data exist regarding older patients' risk of complications. One of the largest studies to date had results suggesting that age was an independent risk factor for complications-specifically, wound infection and delayed healing 12 -but smaller studies have not provided evidence to support this. 16, 17 Previous work from our group using this cohort found that active smoking and morbid obesity were the strongest predictors of major surgical complications. 18 We felt that the effect of age is important to understand in this population, necessitating further analysis in this manuscript. The purpose of this study was to further examine the topic on a populationbased level in an effort to educate practitioners who treat this complex population. Ultimately, the goal is to aid in perioperative decision making for aging patients with symptomatic macromastia who present for potential breast reduction surgery. Based on our analysis, these patients are not at increased risk for infection or wound dehiscence compared to younger patients. Our ACS NSQIP database query returned a total of 3537 cases of reduction mammaplasty, the largest cohort in the literature focused on examining the impact of age on surgical outcomes for this procedure. Again, age does not seem to play a factor in early 30-day postoperative complications, as defined by our study. The ACS NSQIP database has been used to understand the effects of age on overall surgical complications. 19 When controlling for risk factors associated with the aging patient-decreased activities in daily living or increased American Society of Anesthesiologists scores-age still remained an independent predictor of poor surgical outcome. In terms of elective surgery in particular, older patients have been shown to have a significantly increased risk of mortality for a number of common procedures. [20] [21] [22] These studies emphasize that considerable care should be taken when electing to operate on older patients, regardless of procedure.
There has been debate in the literature over the effects of age on surgical outcomes in reduction mammaplasty. The results of the BRAVO study, 17 which included 179 patients over 9 months, demonstrated that age was inversely related to delayed wound healing (P < .011), although the authors were unable to explain why this finding contradicted what is known about the relationship between younger age and improved wound healing. 23 Our results appear contrary to a previous single-institution case series that addressed this issue. Shermak et al 12 analyzed 1192 cases over a 10-year period and found that an age of greater than 50 years was an independent predictor for postoperative infection. The authors believed that the changing estrogen levels of women this age played a role in postoperative wound-healing difficulties. In this cohort, women on hormone-replacement therapy had improved outcomes, while women who underwent hysterectomy/ oophorectomy had poorer outcomes. Multiple animal 24, 25 and human 13, 26 studies have attempted to understand the significant relationship between increased estrogen levels and enhanced wound healing. It appears that estrogen reduces local inflammation, increasing the body's ability to heal wounds. We were limited by the variables in the ACS NSQIP database and were unable to assess the specific role of estrogen levels in our cohort, although we did not see an increased risk of wound complications based on increased age (P = .36).
The results of this study demonstrate that reduction mammaplasty can be safely performed on elderly patients. However, appropriate patient selection and counseling are essential. The risk profile established by this study shows that the procedure should be offered to older patients who may receive significant benefit. Our results are derived from the overall cohort, but there is no doubt that risks remain when operating on older patients and those with a large number of comorbidities. It is also important to note that the young elderly (60-70 years) may be a very different population than patients older than 70 years. It is essential to recognize that older patients often present with higher rates of preexisting medical conditions and that these conditions must be managed appropriately at the time of surgery. This was demonstrated in our preoperative patient Return to operating room 62 (2.0) 6 (1.2) .29
Myocardial infarction 0 (0.0) 1 (0.2) .14 a There was no incidence of 30-day postoperative pneumonia, renal insufficiency, renal failure, or septic shock in our cohort.
characteristics; older patients were noted to have a significantly higher American Society of Anesthesiologists score. We advocate for appropriate preoperative screening to ensure that elderly patients are good surgical candidates. The necessary screening may be more intensive than what would normally be undertaken for younger patients and should include a thorough history and physical. Further preoperative evaluation should be based on the presence or absence of preoperative risk factors. The preoperative workup should reflect the fact that reduction mammaplasty is a low-risk procedure with a small chance for significant blood loss. Basic laboratory tests and imaging, including chest radiograph and echocardiography, should be obtained only in select patients based on risk factors and physical examination findings. [27] [28] [29] For patients with known cardiac risk factors, preoperative workup may also include clearance from a primary care doctor or cardiologist. Furthermore, patients with a history of wound-healing difficulties or smoking must be counseled appropriately about their increased risk of postoperative complications. Last, postoperative care for the elderly population must take a conservative approach with a focus on appropriate wound care and rehabilitation. (Postoperative care was not specifically assessed by our study analysis.) Resected specimens from older patients must also be sent to pathology due to the potential for discovering occult breast carcinoma. 30 Patients must be made aware during their initial surgical consultation that this will occur.
Use of the ACS NSQIP database has proven effective in answering difficult questions in multiple areas of surgical literature, 31,32 but it is not without its weaknesses. The external validity of the ACS NSQIP database is limited by its members and collection biases. This study was hindered by the database variables, which lack many important characteristics of aging patients and outcomes specific to reduction mammaplasty, such as type of reduction pattern, amount of resected tissue, preoperative distance measurements, nipple necrosis, fat necrosis, and long-term delayed wound healing. Outcomes were documented for only 30 days postoperatively, limiting the ability to generalize our results to any surgical complication that occurs in the immediate postoperative period (DSSI, SSSI, unplanned return to the operating room, wound dehiscence). This is a concern because there are many factors other than operative complications that can define a "successful" procedure. The database does not mention the aesthetic outcome or postoperative patient satisfaction, an important measure in reduction mammaplasty. 33 A composite variable was used as our primary outcome of interest to increase the power of our study. However, complications that have been demonstrated to be the most common, such as wound infection and dehiscence, were study-specific variables.
concluSionS
The results of this study, which utilized the ACS NSQIP data set, demonstrated that age was not a significant risk factor for early postoperative complications following reduction mammaplasty. Older patients with symptomatic macromastia can be offered this procedure as a surgical option, given appropriate counseling and preoperative evaluation. The significant quality-of-life benefits provided by this surgical procedure should not be reserved for younger patients.
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